Originally approved for treating Type 2 diabetes, semaglutide is now FDA-approved for chronic weight management in adults with obesity or those struggling with weight-related health conditions
Xiao L, Zhang H, Wang Y, Li J, Yang G, Wang L, et al
GLP-1 hormone activation GLP-1 is the hormone semaglutide is designed to mimic, and its presence sends signals throughout the body
If you are not seeing results after a few months of taking semaglutide, consult your healthcare provider and consider the following factors: Confirm whether you are on a full therapeutic dose or a low dose
Proper injection technique is foundational: rotating injection sites with each weekly dose helps prevent localized irritation and allows previously used areas to recover fully